Sponsor or institution
Clinical trials and research at Kathera Bioscience INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Broad-spectrum DHFR inhibitors for dangerous fungal infections
A new DHFR-targeting drug approach aims to treat life-threatening fungal infections that are hard to manage with current medicines.
-
New treatments for serious fungal infections
This study is working on new medicines that can help fight serious fungal infections, especially for patients who don’t respond to current treatments, by targeting a specific enzyme that fungi need to survive.
-
Developing new drugs to treat serious fungal infections
This study is working on making better medicines for serious fungal infections, like those caused by Candida albicans, by redesigning current drugs to target important genes in the fungi, so that people can have more effective treatments, especially if their infections are resistant to existing options.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.